Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma

NCT06470217 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: tirilizumab with albumin-bound paclitaxel and cisplatin
PROCEDURE: surgery

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University